Patents by Inventor Caroline Isabelle Bacon Kurtz

Caroline Isabelle Bacon Kurtz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anionic Polymers as Toxin Binders and Antibacterial Agents
    Publication number: 20100172861
    Abstract: The present invention relates to a method of inhibiting a toxin in an animal, such as a human, by administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. The spacer group can have a length in the range from 0 to about 20 atoms. The toxin is, typically, an exotoxin secreted by a pathogenic microorganism, such as a bacterium.
    Type: Application
    Filed: January 15, 2010
    Publication date: July 8, 2010
    Applicant: GENZYME CORPORATION
    Inventors: Caroline Isabelle Bacon Kurtz, Richard Fitzpatrick
  • Anionic polymers as toxin binders and antibacterial agents
    Patent number: 7678369
    Abstract: The present invention relates to a method of inhibiting a toxin in an animal, such as a human, by administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. The spacer group can have a length in the range from 0 to about 20 atoms. The toxin is, typically, an exotoxin secreted by a pathogenic microorganism, such as a bacterium.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: March 16, 2010
    Assignee: Genzyme Corporation
    Inventors: Caroline Isabelle Bacon Kurtz, Richard Fitzpatrick
  • Anionic polymers as toxin binders and antibacterial agents
    Patent number: 6890523
    Abstract: The present invention relates to a method of inhibiting a toxin in an animal, such as a human, by administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. The spacer group can have a length in the range from 0 to about 20 atoms. The toxin is, typically, an exotoxin secreted by a pathogenic microorganism, such as a bacterium.
    Type: Grant
    Filed: November 14, 2002
    Date of Patent: May 10, 2005
    Assignee: Genzyme Corporation
    Inventors: Caroline Isabelle Bacon Kurtz, Richard Fitzpatrick
  • Ionic polymers as toxin-binding agents
    Patent number: 6692732
    Abstract: A method for treating pathogenic toxins in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising a cationic group attached to the polymer backbone. The polymer can be a homopolymer or a copolymer. In one embodiment, the polymer is a copolymer comprising a monomer having a pendant ammonium group and a hydrophobic monomer.
    Type: Grant
    Filed: December 19, 2002
    Date of Patent: February 17, 2004
    Assignee: Genzyme Corporation
    Inventors: Richard Fitzpatrick, Chad Cori Huval, Caroline Isabelle Bacon Kurtz, W. Harry Mandeville, III, Thomas X. Neenan
  • IONIC POLYMERS AS TOXIN-BINDING AGENTS
    Publication number: 20040009145
    Abstract: A method for treating pathogenic toxins in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising a cationic group attached to the polymer backbone. The polymer can be a homopolymer or a copolymer. In one embodiment, the polymer is a copolymer comprising a monomer having a pendant ammonium group and a hydrophobic monomer.
    Type: Application
    Filed: December 19, 2002
    Publication date: January 15, 2004
    Applicant: GelTex Pharmaceuticals, Inc.
    Inventors: Richard Fitzpatrick, Chad Cori Huval, Caroline Isabelle Bacon Kurtz, W. Harry Mandeville, Thomas X. Neenan
  • Anionic polymers as toxin binders and antibacterial agents
    Publication number: 20030138397
    Abstract: The present invention relates to a method of inhibiting a toxin in an animal, such as a human, by administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. The spacer group can have a length in the range from 0 to about 20 atoms. The toxin is, typically, an exotoxin secreted by a pathogenic microorganism, such as a bacterium.
    Type: Application
    Filed: November 14, 2002
    Publication date: July 24, 2003
    Applicant: GelTex Pharmaceuticals, Inc.
    Inventors: Caroline Isabelle Bacon Kurtz, Richard Fitzpatrick
  • Anionic polymers as toxin binders and antibacterial agent
    Patent number: 6517827
    Abstract: The present invention relates to a method of inhibiting a toxin in an animal, such as a human, by administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. The spacer group can have a length in the range from 0 to about 20 atoms. The toxin is, typically, an exotoxin secreted by a pathogenic microorganism, such as a bacterium.
    Type: Grant
    Filed: July 9, 2001
    Date of Patent: February 11, 2003
    Assignee: GelTex Pharmaceuticals, Inc.
    Inventors: Caroline Isabelle Bacon Kurtz, Richard Fitzpatrick
  • Anionic polymers as toxin binders and antibacterial agents
    Patent number: 6517826
    Abstract: The present invention relates to a method of inhibiting a toxin in an animal, such as a human, by administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. The spacer group can have a length in the range from 0 to about 20 atoms. The toxin is, typically, an exotoxin secreted by a pathogenic microorganism, such as a bacterium.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: February 11, 2003
    Assignee: GelTex Pharmaceuticals, Inc.
    Inventors: Caroline Isabelle Bacon Kurtz, Richard Fitzpatrick
  • Ionic polymers as toxin-binding agents
    Publication number: 20020114774
    Abstract: A method for treating pathogenic toxins in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising a cationic group attached to the polymer backbone. The polymer can be a homopolymer or a copolymer. In one embodiment, the polymer is a copolymer comprising a monomer having a pendant ammonium group and a hydrophobic monomer.
    Type: Application
    Filed: July 24, 2001
    Publication date: August 22, 2002
    Applicant: GelTex Pharmaceuticals, Inc.
    Inventors: Richard Fitzpatrick, Chad Cori Huval, Caroline Isabelle Bacon Kurtz, W. Harry Mandeville, Thomas X. Neenan
  • Anionic polymers as toxin binders
    Patent number: 6419914
    Abstract: The present invention relates to a method of inhibiting a toxin in an animal, such as a human, by administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. The spacer group can have a length in the range from 0 to about 20 atoms. The toxin is, typically, an exotoxin secreted by a pathogenic microorganism, such as a bacterium.
    Type: Grant
    Filed: June 11, 2001
    Date of Patent: July 16, 2002
    Assignee: GelTex Pharmaceuticals, Inc.
    Inventors: Caroline Isabelle Bacon Kurtz, Richard Fitzpatrick
  • Anionic polymers as toxin binders
    Publication number: 20010041171
    Abstract: The present invention relates to a method of inhibiting a toxin in an animal, such as a human, by administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. The spacer group can have a length in the range from 0 to about 20 atoms. The toxin is, typically, an exotoxin secreted by a pathogenic microorganism, such as a bacterium.
    Type: Application
    Filed: June 11, 2001
    Publication date: November 15, 2001
    Applicant: GelTex Pharmaceuticals, Inc.
    Inventors: Caroline Isabelle Bacon Kurtz, Richard Fitzpatrick
  • Ionic polymers as toxin-binding agents
    Patent number: 6290947
    Abstract: A method for treating pathogenic toxins in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising a cationic group attached to the polymer backbone. The polymer can be a homopolymer or a copolymer. In one embodiment, the polymer is a copolymer comprising a monomer having a pendant ammonium group and a hydrophobic monomer.
    Type: Grant
    Filed: June 19, 2000
    Date of Patent: September 18, 2001
    Assignee: GelTex Pharmaceuticals, Inc.
    Inventors: Richard Fitzpatrick, Chad Cori Huval, Caroline Isabelle Bacon Kurtz, W. Harry Mandeville, III, Thomas X. Neenan
  • Anionic polymers as toxin binders and antibacterial agents
    Patent number: 6290946
    Abstract: The present invention relates to a method of inhibiting a toxin in an animal, such as a human, by administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. The spacer group can have a length in the range from 0 to about 20 atoms. The toxin is, typically, an exotoxin secreted by a pathogenic microorganism, such as a bacterium.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: September 18, 2001
    Assignee: GelTex Pharmaceuticals, Inc.
    Inventors: Caroline Isabelle Bacon Kurtz, Richard Fitzpatrick
  • Anionic polymers as toxin binders
    Patent number: 6270755
    Abstract: The present invention relates to a method of inhibiting a toxin in an animal, such as a human, by administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. The spacer group can have a length in the range from 0 to about 20 atoms. The toxin is, typically, an exotoxin secreted by a pathogenic microorganism, such as a bacterium.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: August 7, 2001
    Assignee: GelTex Pharmaceuticals, Inc.
    Inventors: Caroline Isabelle Bacon Kurtz, Richard Fitzpatrick